These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 2862369)

  • 1. Differentiation between allograft rejection and cyclosporin nephrotoxicity in renal-transplant recipients.
    Taube DH; Neild GH; Williams DG; Cameron JS; Hartley B; Ogg CS; Rudge CJ; Welsh KI
    Lancet; 1985 Jul; 2(8448):171-4. PubMed ID: 2862369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Morphological differentiation between rejection and cyclosporin nephrotoxicity in renal allografts.
    Neild GH; Taube DH; Hartley RB; Bignardi L; Cameron JS; Williams DG; Ogg CS; Rudge CJ
    J Clin Pathol; 1986 Feb; 39(2):152-9. PubMed ID: 3512613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood cyclosporin concentrations and renal allograft dysfunction.
    Holt DW; Marsden JT; Johnston A; Bewick M; Taube DH
    Br Med J (Clin Res Ed); 1986 Oct; 293(6554):1057-9. PubMed ID: 3094774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Biopsy findings in kidney transplants after treatment with cyclosporin A].
    Nizze H; Gokel JM; Lang W; Mihatsch MJ
    Zentralbl Allg Pathol; 1986; 132(5-6):423-33. PubMed ID: 3551394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnetic resonance imaging of renal transplants: its value in the differentiation of acute rejection and cyclosporin A nephrotoxicity.
    te Strake L; Schultze Kool LJ; Paul LC; Tegzess AM; Weening JJ; Hermans J; Doornbos J; Bluemm RG; Bloem JL
    Clin Radiol; 1988 May; 39(3):220-8. PubMed ID: 3293883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differentiation between renal allograft rejection and cyclosporine toxicity: a clinicopathological study.
    Alexopoulos E; Leontsini M; Daniilidis M; Sakellariou G; Visvardis G; Papadimitriou M
    Am J Kidney Dis; 1991 Jul; 18(1):108-15. PubMed ID: 2063842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclosporin and renal graft histology.
    d'Ardenne AJ; Dunnill MS; Thompson JF; McWhinnie D; Wood RF; Morris PJ
    J Clin Pathol; 1986 Feb; 39(2):145-51. PubMed ID: 3512612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal histopathology in kidney transplant recipients immunosuppressed with cyclosporin A: results of an international workshop.
    Clin Nephrol; 1985 Sep; 24(3):107-19. PubMed ID: 3899437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histopathological changes in cyclosporin-treated renal allografts biopsied at one and twelve months.
    Bignardi L; Neild GH; Hartley RB; Taube DH; Cameron JS; Rudge CJ; Williams DG; Ogg CS
    Nephrol Dial Transplant; 1987; 2(5):366-70. PubMed ID: 3122115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Differential diagnosis of rejection and cyclosporin nephrotoxicity in organ transplantation using exfoliative urinary cytology].
    Stella F; Alfani D; Stella C; Battistelli S; Troccoli R; Cortesini R
    Quad Sclavo Diagn; 1985 Sep; 21(3):330-40. PubMed ID: 3915106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Morphology of cyclosporine nephrotoxicity and acute rejection in patients immunosuppressed with cyclosporine and prednisone.
    Sibley RK; Rynasiewicz J; Ferguson RM; Fryd D; Sutherland DE; Simmons RL; Najarian JS
    Surgery; 1983 Aug; 94(2):225-34. PubMed ID: 6348988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistological analysis of renal allograft biopsies from cyclosporin-treated patients. Induced HLA-class II antigen expression does not exclude a diagnosis of cyclosporin nephrotoxicity.
    Fuggle SV; McWhinnie DL; Morris PJ
    Transpl Int; 1989 Oct; 2(3):123-8. PubMed ID: 2679626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is there a therapeutic range for monitoring plasma cyclosporin in renal allograft recipients?
    Ubhi CS; Woodhouse L; Guillou PJ; Giles GR
    Nephrol Dial Transplant; 1988; 3(6):814-9. PubMed ID: 3147426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis of renal allograft rejection by macrophage immunostaining with a CD14 monoclonal antibody, WT14.
    Bogman MJ; Dooper IM; van de Winkel JG; Tax WJ; Hoitsma AJ; Assmann KJ; Ruiter DJ; Koene RA
    Lancet; 1989 Jul; 2(8657):235-8. PubMed ID: 2474119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective conversion from azathioprine to cyclosporin for steroid-resistant rejection in renal transplants: an alternative therapy.
    Crowson MC; Berisa F; McGonigle RJ; Adu D; Michael J; Barnes AD
    Nephrol Dial Transplant; 1989; 4(2):129-32. PubMed ID: 2496354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The detection of renal allograft rejection by fine-needle intrarenal manometry.
    Wilson RG; Taylor RM; Proud G
    Br J Surg; 1985 Oct; 72(10):816-8. PubMed ID: 3899243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical diagnosis and management of the renal transplant recipient with cyclosporine nephrotoxicity.
    Diethelm AG
    Transplant Proc; 1986 Apr; 18(2 Suppl 1):82-91. PubMed ID: 3515700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination fine-needle aspiration cytology and intrarenal manometry at the onset of renal dysfunction.
    Ubhi CS; Guillou PJ; Davison AM; Giles GR
    Br J Surg; 1987 Apr; 74(4):297-300. PubMed ID: 3555693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The diagnosis of cyclosporin nephrotoxicity in patients after kidney transplantation].
    Rozental' RL; Il'inskiĭ IM; Bitsans IaB; Strokan' VA
    Ter Arkh; 1990; 62(6):92-4. PubMed ID: 2218937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interstitial fibrosis in renal allografts after 12 to 46 months of cyclosporin treatment: beneficial effect of low doses in early post-transplantation period.
    Klintmalm G; Bohman SO; Sundelin B; Wilczek H
    Lancet; 1984 Oct; 2(8409):950-4. PubMed ID: 6149343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.